info@synchemia.com | sales@synchemia.com 
9766925136 | 72 
N-Nitroso Enzalutamide Impurity 1
.png)
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Enzalutamide is used to treat castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone), and metastatic castration-sensitive prostate cancer (prostate cancer that has spread to other parts of the body and responds to a hormone therapy or surgical.N-Nitroso Enzalutamide Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Enzalutamide Impurity 1 CAS NO:NA chemically represented as N-(4-Cyano-3-(trifluoromethyl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of N-Nitroso Enzalutamide Impurity 1.We supply N-Nitroso Enzalutamide Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0142724 |
| CAS No | NA |
| Mol.F. | C24H16Cl2N4O2 |
| Mol.Wt. | 463.32 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142725 |
| CAS No | NA |
| Mol.F. | C12H8N4O |
| Mol.Wt. | 224.22 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142726 |
| CAS No | NA |
| Mol.F. | C21H23N3O9 |
| Mol.Wt. | 463.44 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142727 |
| CAS No | NA |
| Mol.F. | C24H21N3O7 |
| Mol.Wt. | 463.44 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142728 |
| CAS No | NA |
| Mol.F. | C18H19N3O8 |
| Mol.Wt. | 405.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142729 |
| CAS No | NA |
| Mol.F. | C27H29N3O8 |
| Mol.Wt. | 523.54 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142730 |
| CAS No | NA |
| Mol.F. | C27H27N3O8 |
| Mol.Wt. | 521.53 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142731 |
| CAS No | NA |
| Mol.F. | C16H11ClN4O5 |
| Mol.Wt. | 374.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142732 |
| CAS No | NA |
| Mol.F. | C15H11ClN4O2 |
| Mol.Wt. | 314.73 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142733 |
| CAS No | NA |
| Mol.F. | C15H9Cl2N3O5 |
| Mol.Wt. | 382.15 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142734 |
| CAS No | NA |
| Mol.F. | C15H9ClN4O4 |
| Mol.Wt. | 344.71 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142735 |
| CAS No | NA |
| Mol.F. | C13H7ClN4O3 |
| Mol.Wt. | 302.67 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142736 |
| CAS No | NA |
| Mol.F. | C20H11Cl2N3O5 |
| Mol.Wt. | 444.22 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142737 |
| CAS No | NA |
| Mol.F. | C15H9BrClN3O5 |
| Mol.Wt. | 426.61 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142738 |
| CAS No | NA |
| Mol.F. | C23H13ClN4O7 |
| Mol.Wt. | 492.83 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142739 |
| CAS No | NA |
| Mol.F. | C15H9BrClN3O5 |
| Mol.Wt. | 426.61g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
